Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasm, Residual × palbociclib × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Pancreatic Neoplasms 2 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Medulloblastoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

venetoclax 1 palbociclib 1 fludarabine 1 asparaginase erwinia chrysanthemi recombinant 1 Zymosan 1 Letrozole 1 Idarubicin 1 Etoposide 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡